Syphilis Treatment Drugs Sector: Growth Drivers and Challenges
Growth Drivers
- Increasing Incidences of Unprotected Sex Worldwide
- Growing Occurrence of Syphilis in Developing Nations
Challenges
- Lack of Trained Laboratory Personnel in Under Developed Nations
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Syphilis Treatment Drugs Market size is expected to register remarkable growth rate during the forecast period i.e., between 2025-2037.
Increasing incidences of unprotected sex worldwide and growing occurrence of syphilis in developing nations will impel the market growth.
North America industry is predicted to hold largest revenue share by 2037, on the back of high awareness about the disease, favorable public health insurance plans and growing advancements in the healthcare sector.
The major players in the market are GlaxoSmithKline plc, Johnson & Johnson Services, Inc., F. Hoffman-La Roche Ltd, Abbott Laboratories, PerkinElmer, Inc., and others.
